-
Genome editing strategies to generate working models in Polycystic Kidney Disease
Dataset
EGAD50000001694
-
scRNA-seq of bronchoalveolar lavage (BAL) samples from patients with severe COVID-19 to assess dexamethasone response in the lungs
Dataset
EGAD50000000292
-
SARS-CoV2 mRNA-vaccination-induced Immunological Memory in Human Non-Lymphoid and Lymphoid Tissues
Dataset
EGAD50000000062
-
BBMRI – BIOS – Freeze 2 – RNA-seq Counts
Dataset
EGAD00010001420
-
RNA-Seq of primary pediatric kidney tumor controls for the soft tissue sarcoma tumoroid biobank
Dataset
EGAD00001008709
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Dataset
EGAD00001006426
-
WES, ultra-deep sequencing exome and RNAseq data of diseased liver samples
Dataset
EGAD00001004792
-
Paired-end RNA-seq analysis of the Hypermutation and Malignant Progression in Low-grade Glioma Patients
Dataset
EGAD00001005387
-
Merged single-cell RNA-seq data for 22 Hodgkin lymphomas and 5 reactive lymph nodes
Dataset
EGAD00001006221
-
single-cell RNA sequencing data of BALF and blood cells obtained from COPD patients and control donors
Dataset
EGAD00001006069
-
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140
Dataset
EGAD00001006186
-
Single-cell RNA-seq counts and merged data for 28 Hodgkin lymphomas and 5 reactive lymph nodes
Dataset
EGAD00001008270
-
Bulk RNAseq: Transcriptomic profiling of human primary pulmonary artery endothelial cells before and after over-expression of KLF factors
Dataset
EGAD50000002680
-
RNA-Seq dataset of Targeting the dark proteome to expand the lineage-retained antigen landscape in neuroblastoma
Dataset
EGAD00001016124
-
Deep single-cell RNA sequencing data for 11138 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive CRC patients. The DATA ACCESS AGREEMENT is provided at https://github.com/zhangyybio/single-T-cell-data-access. Applicants can request access to the data by directly downloading it or by sending an email to cancerpku@pku.edu.cn. The process that is used to approve an application includes verifying the institution, participants and research purposes of the application. In general this process will take about two weeks. In principal, any scientific research program complying with the laws and bioethic regulation policies of China will be approved.
Study
EGAS00001002791
-
Avelumab or M7824 for People with Recurrent Respiratory Papillomatosis
Study
phs002373
-
Leveraging Extended Families for Cardiovascular Disease Genomic Discovery
Study
phs002464
-
Single Nucleus Transcriptomes from the Ventral Midbrain of Opioid Overdose Cases and Controls
Study
phs003260
-
Single-cell analysis of upper airway cells reveals host-viral dynamics in influenza infected adults
Study
phs002039
-
Novel Approach to High-Throughput Identification and Characterization of Neoantigens
Study
phs002372
-
Protracted Neuronal Recruitment in the Temporal Lobe of Young Children
Study
phs003509
-
Pyoderma Gangrenosum Caused by Molecular Uncoupling of OTULIN Catalytic Activity and LUBAC Binding
Study
phs004114
-
The single plasma-cell transcriptional landscape in POEMS syndrome
Study
JGAS000289
-
Transcriptional effect of 4HTBZ on Caco-2 cells
Study
EGAS50000001237
-
Splicing signature analysis of RNU4-2, RNU5A-1 and RNU5B-1
Study
EGAS50000000889